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Key points
 Therapeutic hypothermia (HT) to 33.0–34.0°C for 72 h provides optimal therapy for
infants with neonatal encephalopathy (NE) in high-resource settings. HT is not universally
implemented in low- and middle-income countries as a result of both limited resources and
evidence.
 Facilitated passive cooling, comprising infants being allowed to passively lower their body
temperature in the days after birth, is an emerging practice in some West African neonatal
units.
 In this observational study, we demonstrate that infants undergoing facilitated passive cooling
in a neonatal unit in Accra, Ghana, achieve temperatures within the HT target range 20%
of the 72 h. Depth of HT fluctuates and can be excessive, as well as not maintained, especially
after 24 h.
 Sustained and deeper passive cooling was evident for severe NE and for those that died.
 It is important to prevent excessive cooling, to understand that severe NE babies cool more
and to be aware of facilitated passive cooling with respect to the design of clinical trials in low-
and mid-resource settings.
Christabel Enweronu-Laryea is an Associate Professor of Paediatrics and Child Health, University of
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the evolution of perinatal asphyxia in low-resource tropical settings led to present study being conducted.
Perinatal asphyxia is a major cause of preventable death and long-term impairment in sub-Saharan
Africa. Accordingly, her research aspirations include finding cost-effective interventions that improve the
health outcomes of affected infants. KathrynMartinello is a consultant neonatologist at Great Ormond
Street Hospital, London, UK, and an honorary research associate with the Institute for Women’s Health,
University College London. She is a PhD candidate at the Robinson Research Institute, University
of Adelaide, Australia, supervised by Assistant Professor Michael Stark and Professor Nicola Robertson
(UCL). Her research, both clinical and preclinical, is centred on improving neurodevelopmental outcome
and protecting the newborn brain following perinatal asphyxia across all settings.
∗These authors contributed equally to this work.
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society DOI: 10.1113/JP277820
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution
and reproduction in any medium, provided the original work is properly cited.
2 C. Enweronu-Laryea and others J Physiol 0.0
Abstract Neonatal encephalopathy (NE) is a significant worldwide problem with the greatest
burden in sub-Saharan Africa. Therapeutic hypothermia (HT), comprising the standard of care
for infantswithmoderate-to-severeNE in settingswith sophisticated intensive care, is not available
to infants in many sub-Saharan African countries, including Ghana. We prospectively assessed
the temperature response in relation to outcome in the 80 h after birth in a cohort of babies
with NE undergoing ‘facilitated passive cooling’ at Korle Bu Teaching Hospital, Accra, Ghana.
We hypothesized that NE infants demonstrate passive cooling. Thirteen infants (69% male)
36 weeks with moderate-to-severe NE were enrolled. Ambient mean ± SD temperature was
28.3± 0.7°C. Infant core temperature was 34.2± 1.2°C over the first 24 h and 35.0± 1.0°C over
80h.Nadirmean temperatureoccurred at 15h.Temperatureswerewithin target range forHTwith
respect to 18± 14% of measurements within the first 72 h. Axillary temperature was 0.5± 0.2°C
below core. Three infants died before discharge. Core temperature over 80 h for surviving infants
was 35.3± 0.9°Cand33.96± 0.7°C for those that died (P= 0.043). Temperature profile negatively
correlated with Thompson NE score on day 4 (r2 = 0.66): infants with a Thompson score of 0–6
had higher temperatures than those with a score of 7–15 (P= 0.021) and a score of 16+/deceased
(P = 0.007). More severe NE was associated with lower core temperatures. Passive cooling is
a physiological response after hypoxia–ischaemia; however, the potential neuroprotective effect
of facilitated passive cooling is unknown. An awareness of facilitated passive cooling in babies
with NE is important for the design of clinical trials of neuroprotection in low and mid resource
settings.
(Received 12 February 2019; accepted after revision 25 April 2019; first published online 9 May 2019)
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Introduction
Intrapartum-related hypoxic events are a major cause
of neonatal mortality and morbidity in low- and
mid-income countries (LMIC). Neonatal encephalopathy
(NE) secondary to intrapartum events is estimated to
affect 1.16 million babies per year, with the highest
rates occurring in sub-Saharan Africa (Lee et al. 2013).
NE manifests with neurological dysfunction in the first
days of life, including difficulty initiating and sustaining
respiration, abnormal level of consciousness, depression
of tone and reflexes, and, in many cases, seizures
(Nelson & Leviton, 1991). Globally each year, NE is
estimated to cause 287,000 deaths and over 50 million
disability adjusted life years (Lee et al. 2013). NE is
the second most common cause of avoidable childhood
neurodevelopmental disability worldwide (Lawn et al.
2014). Reducing preventable neonatal death is a global
Sustainable Development Goal (United Nations, 2015).
Ghana is a middle-income country with 800,000
births per year. Intrapartum-related hypoxic events
account for around one-third of all newborn deaths
and are among the top 10 causes of all deaths in the
country (WHO, 2016). NE is a major cause of disability
in Ghanaian children (Adei-Atiemo et al. 2015). During
a 6 month period in 2015, birth asphyxia accounted
for 30% of the 966 neonatal unit admissions at Korle
Bu Teaching Hospital (KBTH) in Accra, Ghana (Samba,
2017). Twenty-two percent of cases referred to KBTHwith
perinatal asphyxia died. Four out of five normal birth
weight termdeaths at KBTHneonatal unit were associated
with intrapartum-related hypoxic events.
Therapeutic hypothermia (HT) is standard clinical care
for infants with moderate-to-severe NE in high-income
countries (National Institute for Health and Care
Excellence, 2010). Cooling to 33.5°C for 72 h within 6 h
of birth improves outcomes of death and neurodisability
in the short (Edwards et al. 2010; Jacobs et al. 2013) and
longer term (Guillet et al. 2012; Shankaran et al. 2012).
In high income settings, the implementation of HT over
the past decade has benefited patients, society and the
economy (Azzopardi et al. 2012).
Despite the high burden of NE in Ghana and other
LMIC, there is no readily available and affordable
evidence-based therapy for NE beyond supportive
care. Modern technologies for providing HT and
comprehensive monitoring of affected babies remain
beyond the reach of many hospitals. A systematic review
combining studies from LMIC settings suggested that HT
was not associated with a reduction in neonatal mortality,
although the confidence intervals were wide (Pauliah
et al. 2013). Indeed, it is possible that HT may not be
beneficial in low resource settings without sophisticated
neonatal intensive care unit (NICU) care: a pilot study
in a sub-Saharan African hospital showed that cooling for
72h with water bottles was feasible but was associated with
increased mortality, although the study was not powered
for outcome measures (Robertson et al. 2008).
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An emerging practice in the management of NE in
low resource settings is to facilitate ‘passive cooling’.
Passive cooling is known to occur in babies with NE
in the first hours after birth; this was first described
60 years ago by Burnard and Cross (1958) and has
more recently been observed during neonatal transport
(Kendall et al. 2010), during HT in the NICU (Baumgart,
2008) and in the control arms of low-income setting
cooling studies (Robertson et al. 2008; Thayyil et al.
2013). Diverse methods are used in the management of
intrapartum-related NE in Ghanaian hospitals, including
adapted low-cost cooling technologies, ‘facilitated passive
cooling’ or no intervention. It is not known whether
facilitating passive cooling after perinatal hypoxia
ischaemia is safe and beneficial or whether 72 h of
controlled HT would be preferable in this setting. A better
understanding of the endogenous temperature response
in affected babies is needed to guide recommendations for
the management of NE and the design of future HT trials
in this setting.
The present study aimed: (i) to document the
temperature profile of infantswithmoderate-to-severeNE
over 80 hwhen undergoing typical standardmanagement;
(ii) to explore the relationshipbetween temperatureprofile
andNEseverity and short-termoutcome; and (iii) to assess
the difference in the ‘hypothermia dose’ with facilitated
passive cooling compared to standardHTprotocols typical
of high resource settings.
We hypothesized that infants with NE undergoing
facilitated passive cooling would demonstrate moderate
transient HT.
Methods
Ethical approval
Ethical approval was obtained from the Institutional
Review Board of Korle Bu University Teaching Hospital
(KBTH) (KBTH-IRB 00039/2017).
Study design and participants
This prospective observational cohort pilot study was
conducted in the neonatal unit of the Department of
Child Health at KBTH, in Accra, Ghana. The study
conformed to the standards set by the Declaration of
Helsinki, except for registration in a database. Eligible
infants were recruited between 19 June and 20 July 2017.
Inclusion criteria were: gestation age 36 + 0 weeks,
birth weight 2000 g, postnatal age <24 h and
evidence of moderate-to-severe intrapartum-associated
NE. Moderate-to-severe intrapartum-associated NE was
defined as (i) evidence of intrapartum asphyxia (i.e. need
for bag-mask resuscitation at birth and Apgar score of<6
at 5min of life) and (ii) either a ThompsonNE assessment
score of7 or suspected clinical seizures. Infants in whom
deathwas felt imminent and infants withmajor congenital
malformations were excluded. Infants with swift clinical
recovery following enrolment were subsequently excluded
to allow discharge to the care of their mothers. In
this pilot study, the recruitment of 10–20 infants was
considered feasible during the study period (projected
30–60% recruitment rate, based on 30 NE admissions
per month to KBTH neonatal unit in early 2017).
Procedures
The local research team of selected doctors and nurses
with experience in neonatal care were trained in the
research procedures. Clinical care for participants was
provided by the clinical team of KBTH neonatal unit
and overseen by the attending consultants. Eligible infants
were enrolled after stabilization by the clinical team and
written informed consent (in either English or the local
language) having been provided by the parents. Enrolled
infants were transferred to one of four cot spaces in a
side room reserved for study participants. The decision
to use a side room for conducting the study was made
by the nursing administration of the neonatal unit at
KBTH aiming to minimize disruption to the rest of the
neonatal unit. Temperature management and all aspects
of clinical care were at the discretion of the clinical team
and were not dictated by the study. Standard thermal
care for term infants with NE at KBTH was facilitated
passive cooling, with intermittent surface temperature
monitoring. Infants were dressed in a nappy and nursed
uncovered without an overhead heater in a room without
fans or air-conditioning. At a surface temperature below
34°C, standard practice was to provide warmth with light
linen or blankets to prevent severe HT. The unit did not
have the capacity to routinely monitor core temperature.
Trained medical research personnel completed daily
brief neurological examinations for the first 4 days of
life. These were used to determine a Thompson score
(Thompson et al. 1997), comprising a validated tool for
short-term outcome prediction in NE infants in LMIC
(Horn et al.2013a;Horn et al.2013b; Bhagwani et al.2016),
and a modified Sarnat encephalopathy stage (Shankaran
et al. 2005).
Rectal (core), axillary and ambient air temperatures
were continuously measured (every 1 min) and stored
using amultichannel data logger (Squirrel SQ 2020; Grant
Instruments, Cambridge, UK), from enrolment until 80 h
of age. A nine French thermometer probe (FMT400;
MetkoMedikal, Ankara, Turkey) was inserted3 cm into
the rectum and taped in place. The rectal temperature
probe was manually modified to interface with the data
logger. This was inspected to ensure correct placement at
regular intervals and on an ad hoc basis in case of aberrant
readings, which were transcribed hourly. The axillary
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skin thermometer (Grant Instruments) was taped in the
axilla. The ambient thermometer (Grant Instruments)was
placed on the cot alongside the infant, exposed to the air.
Routine demographic, pregnancy and labour data were
collected from the medical notes and by speaking with
parents. Relevant data from the admission, including the
method of temperature control and the length of hospital
stay, were recorded. Infants were followed until discharge.
Outcome measures
Short-term outcome measures include survival to
discharge and Thompson score on day 4 (0–6,
normal–mild; 7–15, moderate; 16 or deceased, severe)
(Horn et al. 2013a; Horn et al. 2013b).
Statistical analysis
Data are summarized with counts (percentages) for
categorical variables and as themean± SD for continuous
variables. The rectal temperature data (collected every
1 min) was interrogated to exclude erroneous values
and averaged over each hour. Mean rectal temperature
over the first 24 h, as well as mean rectal, axillary and
ambient temperature over the first 80 h, was calculated.
The proportion of time (in minutes) over the first 72 h
after birth that was within, below and above the target
range for standard HT (33.0–34.0°C) was calculated as
a percentage of measured time to account for variable
age at commencement. Temperature values are reported
as the mean ± SD. Using JMP, version 11.0.0 (SAS
Institute Inc., Cary, NC, USA) and SPSS, version 22.0
(IBM Corp., Armonk, NY, USA), a t test or ANOVA
with post hoc Fisher’s least significant difference pairwise
comparison was employed, as appropriate, to compare
temperature data between short-term outcome measures.
A linear regression analysis was undertaken to evaluate
the relationship between Thompson score on day 4
and temperature. In addition, using Prism, version 7.0
(GraphPad Software Inc., San Diego, CA, USA), Pearson’s
correlations were calculated for axillary compared with
core temperature and to assess the impact of potential
confounders, birth weight and phenobarbitone. Analysed
data were normally distributed.
Results
Participants
During the 1-month study period, 43 infantswere assessed
for eligibility and 14 were enrolled (Fig. 1). One infant was
excludedwithin1hof enrolment as a result of rapid clinical
improvement. Thirteen infants, with a mean gestation of
39+ 5 weeks (SD 12 days) andmean± SD birth weight of
3138 ± 463 g were included in the analysis. The majority
of infants had moderate NE (Thompson score 7–15) at
enrolment (85%). Baseline characteristics are listed in
Table 1.
Temperature profile
Standard thermal care with facilitated passive cooling
was implemented for all infants. Temperature recordings
commenced between 1.2 and 26 h of age (median 5 h,
interquartile range 3–12 h). The mean ± SD ambient
temperature in the nursery was 28.3 ± 0.7°C.
The core temperature profile over 80 h for all infants
is shown in Fig. 2A. All infants were hypothermic during
the study period. Mean core temperature over the first
24 h was 34.2 ± 1.2°C and, over 80 h, was 35 ± 1°C.
The nadir mean core temperature was at 15 h of age.
Over the first 72 h after birth, infants spent a mean ± SD
18± 14% (range 0–44%) of the measured time within the
target temperature range for standard HT (33.0–34.0°C);
core temperature was <33.0°C for 11 ± 18% of the time
and >34°C for 71 ± 22% of the time (Table 2). Seven
infants (54%) had temperature recordings less than 33°C,
of which four were between 32.1 to 32.5°C and one was
below 32°C. The one infant who did not reach 33.5°C
(nadir temp 35.1°C at 10.5 h) went on to develop fever
and an elevated C-reactive protein of 350 mg L–1 and
was treated with extended-spectrum I.V. antibiotics for
suspected sepsis.
The depth of HT achieved by these infants had not
been previously recognized because the neonatal unit
lacked the capacity to measure core temperature. To
ensure patient safety, the attending consultant amended
Excluded (n=29)
- Not meeting inclusion criteria (n=14)
- Death imminent (n=7)
- Parents not available to consent (n=7)
- Declined to participate (n=1)
Enrolled (n=14)
Included in analysis (n=13)
- No evidence of NE, well for discharge
   within an hour of enrollment (n=1)
- Lost to follow up (n=0)
Assessed for eligibility
(n=43)
Figure 1. Eligibility flow chart
Flow chart indicating the eligibility of the infants who were enrolled
in the study.
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Table 1. Baseline characteristics, short-term outcome measures
and clinical care during admission
Baseline characteristics and short-term outcome (n = 13)
Gestation (weeks) 39 + 5 ± 1 + 5
Birth weight (g) 3138 ± 463
Male sex (n, %) 9 (69)
Apgar 1 min 3 ± 1.7
Apgar 5 min 4.9 ± 1.7
Thompson score at enrolment 11.3 ± 3
7–15 (n, %) 11 (85)
16+ (n, %) 2 (15)
Sarnat Grade at enrolment (n, %)
Stage 2 10 (77)
Stage 3 3 (23)
Age at enrolment (h) 7.5 ± 7
Onset of labour (n, %)
Spontaneous 10 (77)
Induction 2 (15)
LSCS not in labour 1 (8)
Mode of delivery (n, %)
Vaginal 11 (85)
Emergency LSCS 2 (15)
Duration ROM (n, %)
<18 h 7 (54)
18 h 4 (31)
Unknown 2 (15)
Resuscitation (n, %)
Bag and mask IPPV 13 (100)
Intubation 0 (0)
Chest compressions 0 (0)
Day 4 Thompson score (n, %)
0–6 6 (46)
7–15 4 (31)
16+ 2 (15)
Deceased prior to day 4 1 (8)
Day 4 Sarnat grade (n, %)
Normal/stage I 5 (38)
Stage II 4 (31)
Stage III 3 (23)
Deceased prior to day 4 1 (8)
Deaths (n, %) 3 (23%)
Day 4 Sarnat stage I 0/3
Day 4 Sarnat stage II 1/3
Day 4 Sarnat stage III 2/3
Overall length of hospital stay (days) 10 ± 4.6
Age at discharge home (days) 12 ± 3.8
Feeding at discharge (n, % of survivors)
Exclusive breastfeeding 7 (70)
Breast and cup feeding 3 (30)
Maximal respiratory support (n, %)
None 0 (0)
Oxygen by face mask or nasal prongs 9 (69)
Bubble CPAP 4 (30)
Suspected clinical seizures (n, %) 11 (85)
Received anti-convulsants (n, %)a 10 (77)
(Continued)
Table 1. Continued
Baseline characteristics and short-term outcome (n = 13)
Infection (n, %)
Suspected clinical infection at admission 9 (69)
Received I.V. antibiotics 12 (92)
Received extended spectrum I.V. antibiotics 2 (15)
Blood culture positive (n/number sampled) 0/10
CPAP, continuous positive airway pressure (using heated
humidified blended air and oxygen); LSCS, lower segment
caesarean section; ROM, rupture of membranes; IPPV, inter-
mittent positive pressure ventilation breaths.
aAnti-convulsant therapy for all treated infants commencedwith
phenobarbitone (+/– subsequent phenytoin and midazolam).
Values are the mean ± SD unless specified otherwise.
the temperature management care plan to include the
lower core temperatures recorded by the study thermo-
meters. This amendment was core temperature <33.5°C:
apply one blanket; core temperature <33.2°C: apply a
second blanket; and core temperature <33.0°C: place
infant in an incubator. Five infants had blankets applied
andonewaswarmed in an incubator. Four infants received
heated humidified continuous positive airway pressure for
respiratory support.
Axillary skin temperature was 0.5 ± 0.2 °C below core
rectal temperature (range 0.1–1 °C). There was a close
correlation between mean core and axillary temperature
over 80 h (Pearson’s r2 0.96, P< 0.0001).
Short-term outcome
Short-term outcomes are listed in Table 1. By day 4,
Thompson score had improved to 0–6 for six (46%)
infants; four (30%) infants had persisting moderate
encephalopathy (score 7–15), two were severe (score 16+)
and one infant was deceased. Three infants (23%) died
before discharge: one with moderate NE and two with
severe NE. All surviving infants were discharged home.
Relationship between temperature profile
and outcome
The differences in temperature profile over 80h by
outcome are illustrated in Fig, 2B and C. The 80 h
mean core temperature of infants who died prior to
discharge was 33.96 ± 0.7°C, cooler than 35.3 ± 0.9°C
for those that survived [mean difference 1.4°C, 95%
confidence interval (CI) = 0.1–2.7, P = 0.043]. The
minimum core temperature was also lower for those that
died (31.7 ± 0.9°C) compared to those that survived
(33.3± 0.8°C) (mean difference 1.6°C, 95%CI= 0.3–2.9,
P = 0.022).
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A
B
C
Figure 2. Core temperature profile over
80 h for infants undergoing facilitated
passive cooling (mean ± range)
A, rectal temperature of all infants over the first
80 h after birth. Passive HT is evident, with the
nadir temperature at 15 h. The grey shaded area
is the ‘normothermic’ range, whereas the blue
line represents the target temperature for active
therapeutic HT. Infants who died prior to
discharge (B) and those with moderate and
severe encephalopathy at day 4 (C) had deeper
and more sustained HT.
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Table 2. Proportion of time within the first 72 h after birth that was within, below and above the target range for standard HT
(33.0–34.0°C)
Overall Mortality Day 4 Thompson score
Survived Died 0-6 7–15 16+/ deceased
Mean ± SD Mean ± SD Mean ± SD P value Mean ± SD Mean ± SD Mean ± SD P value
Time measured during
1 s at 72 h after
birth (h)
63.4 ± 7.6 65.0 ± 6.0 58.0 ± 9.4 0.19 64.1 ± 7.4 61.8 ± 9.5 64.0 ± 3.8 0.905
Proportion within HT
target range
(33.0–34.0°C) (%)
17.7 ± 13.8 15.1 ± 13.0 26.4 ± 12.9 0.25 6.7 ± 5.9 29.7 ± 12.3 23.6 ± 9.1 0.015
Proportion time below
33.0°C (%)
11.0 ± 17.9 5.8 ± 6.8 28.4 ± 29.1 0.39 5.3 ± 7.8 5.2 ± 3.4 30.1 ± 27.9 0.125
Proportion time above
34°C (%)
71.3 ± 21.8 79.1 ± 14.4 45.2 ± 21.9 0.015 88.0 ± 8.4 65.0 ± 12.0 46.3 ± 22.1 0.010
Values are presented as overall data and are separated by short-term outcomemeasures (mortality and day 4 Thompson score). Time is
represented as a percentage of time to account for variable commencement time. P values are from an independent t test (mortality)
and an ANOVA (Thompson score). P values < 0.05 are shown in bold.
The mean core temperature over 80 h for infants with
a day 4 Thompson score of 0–6 was 35.8 ± 0.7°C. This
was higher than those infants with a day 4 score of 7–15
(34.5 ± 0.5°C) or 16+/deceased (34.0 ± 0.7°C) (mean
difference 1.3°C, 95% CI = 0.2–2.4, P = 0.021 and
mean difference 1.8°C, 95% CI = 0.6–2.9, P = 0.007,
respectively). The minimum core temperature for the
16+/deceased infants was also lower than that for those
infants with a Thompson score of 0–6 (mean difference
2.0°C, 95% CI = 0.8–3.3°C, P = 0.004). This was
despite the 16+/deceased group being exposed to a higher
mean ambient temperature (mean difference 1.2°C, 95%
CI = 0.3–2.2°C, P = 0.014).
Day 4 Thompson score demonstrated a strong negative
correlation with mean axillary (r2 = 0.71, P = 0.0004),
mean core (r2 = 0.66, P = 0.0007) and minimum core
(r2 = 0.66, P = 0.0008) temperature (Fig. 3). For these
calculations, the one infant who had died prior to day 4
was assigned a Thompson score of 20 out of a possible 22,
which is consistent with their score prior to death.
Infants with a day 4 Thompson score of 7–15 or
16+/deceased spent a greater proportion of the first
72 h within the ‘therapeutic hypothermia’ target range
compared to infants who scored 0–6 (P = 0.006 and
0.043, respectively) (Table 2). Infants who scored 0–6
on day 4 spent a greater proportion of time above 34°C
(P=0.048 and0.004 compared to7–15 and16+/deceased,
respectively), as did infants that survived to discharge
compared to those that died (P = 0.015). There was a
strong positive correlation between day 4 Thompson score
and the proportion of time spent 34 °C in the first 72 h
(Pearson’s r2 = 0.72, P< 0.001).
There was no correlation between day 4 Thompson
score and birth weight (Pearson’s r2 = 0.1). There was
no correlation between core temperature and either birth
weight (Pearson’s r2 = 0.3) or total phenobarbitone
dose kg–1 (Pearson’s r2 = 0.3).
Discussion
In this pragmatic, prospective, observational cohort study
of term babies with moderate to severe NE in a hospital
setting in Ghana, infants were hypothermic during the
first 80 h after birth, even without active induction of HT
(standard care in NICUs typical of high-resource settings)
(National Institute for Health and Care Excellence, 2010).
Temperature management did not include a cooling
device; infants were undressed and covered with a
light blanket in an ambient temperature of 28°C. Core
temperature was within the target range for ‘therapeutic
hypothermia’ (33–34°C) for an average of 18% of the
first 72 h and <33°C for a further 11% of measurements
captured. The nadir temperature occurred at 15h after
birth; most infants recorded core temperatures 33.5°C.
The depth of facilitated passive cooling in the first 80 h
correlated with short-term outcome of death and the
severity of NE.
Facilitated passive cooling is a pragmatic way to try
to optimally manage these babies, as well as cope with
the large number of admissions with NE, staff shortages
and equipment limitations. Passive cooling in newborns
following perinatal hypoxic ischaemic events was first
described byBurnard andCross (1958)whonoted thatNE
infants had lower core temperatures than non-asphyxiated
babies for the first 16 h after birth. Similarly, Dawkins
and Hull (1964) reported a loss of thermogenesis in
rabbit pups during and subsequent to a period of hypo-
xia. More recently, passive cooling was documented in
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infants randomized to the control arm of feasibility
cooling studies in hospital settings in Uganda and India
(Robertson et al. 2008; Thayyil et al. 2013). Indeed, during
standard HT using a servo-controlled water mattress in
high resource NICU settings, the water temperature has
typically been observed to be higher than the infant core
temperature (i.e. the infant often needs ‘warming’ to
33.5°C, particularly in the first 12 h) (Baumgart, 2008).
This period of passive cooling reflects a loss or alteration
of thermoregulation. Usual neonatal responses to cold are
both behavioural (e.g. limb flexion to reduce exposed
surface area and crying to attract maternal attention)
and autonomic [e.g. vasoconstriction and non-shivering
thermogenesis within brown adipose tissue (BAT)]
Figure 3. Relationship between day 4 Thompson score and infant temperature
Linear regression model showing relationship between day 4 Thompson score and mean axillary (A), mean core
(B) and minimum core (C) temperature. There were strong negative correlations between each of these measures
(r2  0.66). The dark shading represents the 95% CI of the mean and the lighter shading indicates the 95%
prediction interval. Infants who died prior to discharge are indicated with a burgundy dot.
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(Jayasinghe, 2015). Newborn infants at term age have a
high proportion of BAT, which enables them to endure
cold stress after birth (Aherne & Hull, 1966). Recognition
of cold stimuli by peripheral and central control centres
may be impaired and behavioural responses to cold may
be lessened by NE. A lack of BAT thermogenesis following
asphyxia may be the result of a loss of energy substrate
and altered central control of thermoregulation. Given the
known neuroprotective benefits of 72 h of controlled HT,
it may be an adaptive survival mechanism. Indeed, passive
cooling in response to hypoxia is evolutionary conserved
throughout many species, suggesting a survival advantage
(Steiner & Branco, 2002).
The severity of NE correlated strongly with the degree
of passive cooling, demonstrating a greater alteration in
thermoregulation in these infants. A loss of BAT activity
is probably central to this. In a cohort of NE infants
undergoing HT in a high resource setting, those infants
with the least need for active cooling intervention to
maintain target temperature had the lowest BAT activity
(Carlisle et al. 2015b); those same infants had a greater
probability of showing evidence of brain injury on MRI
compared to infants who required more active cooling
(Carlisle et al. 2015a). In combination with our findings,
this supports the idea that those infants who are ‘easy to
cool’ are probably more severely affected, at the same time
suggesting that a higher core temperaturemight be a good
prognostic indicator.
The depth of cooling observed in the present study of
facilitated passive cooling was unexpected, particularly for
those infants with severe NE. Almost all of the infants
demonstrated a core temperature of 33.5°C or less during
the first 80 h after birth. Importantly, a number of
infants had core temperatures <32.5°C. Indeed, cooling
to this depth may be hazardous, with an increased risk
of mortality and persistent pulmonary hypertension and
no improvement in outcome at 2 years being seen in
a clinical trial of deeper and longer cooling (Shankaran
et al. 2014; Shankaran et al. 2017). Standard HT (33.5°C
for 72 h) in sophisticated NICU settings is associated
with bradycardia and thromobocytopenia (Jacobs et al.
2013). NICU facilities to manage complications of over-
cooling are not currently available at KBTH, as is
probably also the case formany neonatal units throughout
the world. Given the available evidence regarding the
risks of deep HT, the standard thermal care plan was
amended during the present study. This resulted in the
enrolled infants being warmed by blankets or incubators
to 33.5°C. The use of an incubator accounts for the
increased ambient temperature observed for infants
with severe NE. Affordable and safe technologies for
continuous monitoring of core temperature in infants
undergoing facilitated passive cooling may reduce the risk
of overcooling and related complications in mid- and
low-resource settings.
Pre-clinical studies have been important with respect to
understanding the dose–response of HT. There appears
to be the requirement of a critical brain and body
temperature below 34°C for effective brain protection.
For example, in the fetal sheep undergoing head cooling
from 90 min after ischaemia, neuroprotection was seen
only in fetuses that had a sustained fall of the extradural
temperature to <34°C (Gunn et al. 1997). In the
piglet model, there is a clear U-shaped response of
brain cell death and core temperature after hypoxia
ischaemia; a core temperature reduction of >5°C was
associated with increased cell death and inflammation
compared to cooling by 3.5–5°C (Alonso-Alconada et al.
2015). It is difficult, however, to extrapolate precise
temperatures from these pre-clinical models because their
core temperatures are higher than humans. Regarding
duration of cooling, in the sheep model, 72 h of cooling
provided optimal protection (Davidson et al. 2018a;
Davidson et al. 2019) and the rate of rewarming was of
less importance (Davidson et al. 2018b). Stopping cooling
at 48 h but not 72 h in the fetal sheep was associated
with progressive deterioration of the amplitude integrated
electroencephalogram. However, HT maintained for
24h has proved neuroprotective in rodent and porcine
models (Thoresen et al. 1995; Alonso-Alconada et al.
2015). Preventing passive cooling responses to hypoxia
in a rodent model resulted in an increase in mortality
and brain injury (Reinboth et al. 2016). The implications
of these findings for facilitated passive cooling in settings
without access to sophisticated NICU care are unclear,
such that it is not knownwhether a short period of variable
cooling provides brain protection, although temperatures
below 32.5°C are probably not beneficial.
There are some limitations to thepresent study.Thiswas
intended to be an observational study of usual practice;
however, core temperature data were made available to
the clinical team to ensure safety of enrolled infants. The
availability of continuous core data, rather than inter-
mittent surface temperature data, and the amendment to
the temperature management plan influenced standard
thermal care. This will have resulted in higher mean
temperature recordings for some infants and therefore
the depth of HT achieved with facilitated passive cooling
wasprobablyunderestimated. In addition, enrolled infants
were cared for in a separate room by dedicated research
staff, aiming to avoid disruption to the rest of the neonatal
unit, which may have impacted their care. Long-term
outcome measures are not included in the present study.
Theremay have been other contributors to the observed
core temperature reductions in addition to facilitated
passive cooling post NE. In severely encephalopathic
infants, ongoing postnatal hypoxia as a result of
apnoea and airway compromise may have contributed.
Phenobarbitone, which was administered to 77% of
infants, can cause HT at toxic levels. In an NE cohort, the
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use of phenobarbitone was associated with a modestly
lower core temperature (Sant’Anna et al. 2012). However,
this observation is possibly a result of the severity of brain
injury and the resulting seizure frequency, rather than
a phenobarbitone effect. Phenobarbitone dose was not
associated with core temperature in our cohort. Intra-
uterine growth restriction is associated with an increased
risk of NE (Badawi et al. 1998), as well as postnatal
HT and reduced BAT stores (Aherne & Hull, 1966). In
our cohort, birth weight was not correlated with mean
core temperature or Thompson score and also does not
account for the strong relationship between Thompson
score and temperature. Infection and inflammation are
known contributors to brain injury and encephalopathy
and it is possible that HT may be less efficacious in the
setting of infection (Osredkar et al. 2014; Martinello
et al. 2018). In our cohort, no infants had culture
positive sepsis; however, blood cultures were taken after
commencing antibiotics for some infants. Twelve infants
received antibiotics, whereas two of these went on to
extended spectrum antibiotic coverage as a result of a
strong clinical suspicion of sepsis. One of these infants
did not demonstrate passive cooling beyond 35°C and
later was febrile. It is possible that infection/inflammation
without a hypoxic event was the cause of this infant’s
encephalopathy or, alternatively, that co-existing infection
interfered with facilitated passive cooling.
The benefit of facilitated passive cooling is unknown.
Althogh the infants in the present study reached
temperatures in the target range of HT, these fluctuated
and, on average, were not maintained for more than 20%
of thefirst 72h.Passive coolingwasmost evident in thefirst
24h,withmany infants being above the targetHT rangeon
days 2 and 3. The available preclinical and clinical evidence
suggests that cooling to 33.5°C for 72 h is most beneficial
in the NICU setting (Gunn et al. 2017). However, it is
plausible that these shorter periods of moderate passive
cooling might confer some neuroprotective benefit. We
suggest that active warming of infants with moderate
to severe NE in low- and mid-resource settings to
achieve ‘normothermia’may be detrimental and unethical
until more information is obtained. An awareness of
facilitated passive cooling in babies with NE in low-
and mid-resource settings is important for the design of
clinical trials of neuroprotection in such settings where
the burden of NE is high. However, facilitated passive
cooling may not be sufficiently stable to be used as a
control arm in clinical trials assessing adjunct therapies or
HT itself.
For neonatal units in low- and mid-resource settings
considering the implementation of facilitated passive
cooling, we advise the need for temperature monitoring,
a basic level of neonatal care and dedicated nursing staff
for infants in the acute stages of NE to avoid secondary
brain injury. Careful monitoring of the core temperature
is essential to ensure that excessive cooling does not occur,
particularly for infants with severe NE.
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